Islet transplantation with blood vessel cells shows promise to treat type 1 diabetes

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which requires further development…

Continue ReadingIslet transplantation with blood vessel cells shows promise to treat type 1 diabetes

Harbour BioMed partners with Insilico to accelerate AI-powered antibody discovery

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, and Insilico Medicine ("Insilico"),…

Continue ReadingHarbour BioMed partners with Insilico to accelerate AI-powered antibody discovery

Engineered blood vessel cells boost islet transplant success in diabetes treatment

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.

Continue ReadingEngineered blood vessel cells boost islet transplant success in diabetes treatment